A SERENDIPITOUS DISCOVERY

In 2008, researchers conducting cancer research in immunodeficient mice, noticed that despite the implantation of cancer cells in the mice, unexpectedly, the cancerous cells refused to grow. Baffled, the researchers looked for factors that may have contributed to this mystery.They quickly realized that because of a routine pinworm outbreak in the mice colony, fenbendazole—a standard veterinary antiparasitic used for deworming, was added to the animals’ sterilized feed.

Controlled follow-up experiments clarified the phenomenon: mice were divided into groups receiving standard diet, fenbendazole alone, supplementary vitamins alone, or the combination. Only the fenbendazole-plus-vitamins group exhibited marked tumor growth inhibition, revealing a synergistic antitumor effect that transformed an everyday laboratory housekeeping step into a serendipitous scientific discovery.

The primary mechanism involves fenbendazole’s disruption of microtubules—the cell scaffolding.  If the scaffolding is damaged, the rapidly emerging cell structure collapses (mitotic spindle disruption). Fully built-up healthy cells are not affected by the stress to the scaffolding (microtubules). Fenbendazole’s cytoskeletal interference selectively halts proliferation of cancer cells while sparing normal tissue.

Supporting this action, fenbendazole has also been shown to enhance activity of the p53 tumor suppressor protein, reinforcing cell-cycle checkpoints and programmed-death pathways in malignant cells. In parallel, Fenbendazole interferes with the Warburg effect, where even in an oxygen-rich environment, cancer cells prefer breaking down glucose by fermenting it into lactate for quick energy and for building blocks, instead of oxidizing it in mitochondria. Fenbendazole disrupts these glycolytic pathways that cancer cells hijack. Healthy cells, which rely primarily on oxygen (oxidative phosphorylation), remain largely unaffected by this metabolic reprogramming.

This preclinical observation, formally reported as “Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins,” continues to stimulate targeted fenbendazole research in animal oncology. It stands as a striking illustration of how subtle laboratory variables can illuminate previously unrecognized vulnerabilities in cancer biology.

Source:https://pmc.ncbi.nlm.nih.gov/articles/PMC2687140/

Disclaimer

This information is for educational purposes only and is not intended to replace the advice of a qualified veterinarian.

Virex Health/Virogex Inc.